MolGraph
CompoundsDocumentationComplianceAbout
MolGraph

Research chemical sourcing and molecular building block RFQ workflows.

MolGraph is operated by Tessorix Inc.

support@molgraph.com

Products are intended for laboratory research use only and are not for human or veterinary use.

Compounds

  • Compound catalog
  • CAS Search

Company

  • About
  • Contact

Documentation

  • Quality Documentation
  • SDS Disclaimer

Compliance

  • Compliance

Legal

  • Terms
  • Privacy

Copyright © 2026 MolGraph. All Rights Reserved.

Home/Compounds/CAS 1269440-17-6
Formula C22H27ClFN7O4SMW 540Research-use catalog entryCOA/SDS by request

Encorafenib

CAS Number: 1269440-17-6

Sourcing & RFQ

Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.

Available options

Available Options

Package
10 mg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
100 mg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
25 mg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required
Package
50 mg
Purity
98%
Price
Request review
Availability
Shipping review required
Delivery
Shipping review required

Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.

Loading RDKit molecule structure...
InChIKey: CMJCXYNUCSMDBY-ZDUSSCGKSA-NC22H27ClFN7O4S | MW 540

Chemical Absolute Identifiers

CAS Number

1269440-17-6

PubChem CID

50922675

Molecular Formula

C22H27ClFN7O4S

Molecular Weight

540 g/mol

Exact Mass

539.151779

InChIKey

CMJCXYNUCSMDBY-ZDUSSCGKSA-N

IUPAC Name

methyl N-[(2S)-1-[[4-[3-[5-chloro-2-fluoro-3-(methanesulfonamido)phenyl]-1-propan-2-ylpyrazol-4-yl]pyrimidin-2-yl]amino]propan-2-yl]carbamate

SMILES String

COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1

Physical Properties

No physical property values available.

Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.

Catalog Facts

Structural features

Encorafenib (CAS 1269440-17-6) is listed in the Pharmaceutical Intermediates portfolio, with molecular formula C22H27ClFN7O4S and molecular weight 540. 00 g/mol.

Sourcing context

Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.

Research use context

Intended for research-stage medicinal chemistry and intermediate synthesis workflows; structure-derived tags include nitrogen-containing heterocycle.

Documentation needs

COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.

Applications & Classification

Pharmaceutical Intermediate ResearchResearch intermediateCustom synthesis building blockPharmaceutical intermediate researchResearch chemical sourcingCustom synthesis and catalog availability reviewCOA, SDS, pricing, and fulfillment workflow
Biological target reference

ChEMBL reports experimental activity evidence for: Serine/threonine-protein kinase B-raf (Homo sapiens) — 11 assays; Mitogen-activated protein kinase 14 (Homo sapiens) — 2 assays; Gamma-aminobutyric acid receptor subunit alpha-1 (Rattus norvegicus) — 2 assays; 5-hydroxytryptamine receptor 2B (Homo sapiens) — 2 assays; 5-hydroxytryptamine receptor 1A (Homo sapiens) — 2 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.

Serine/threonine-protein kinase B-raf

Homo sapiens · SINGLE PROTEIN · 11 qualifying assays · 10 documents · best pChEMBL 9.52

Experimental evidence source: ChEMBL

Mitogen-activated protein kinase 14

Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 2 documents · best pChEMBL 5.66

Experimental evidence source: ChEMBL

Gamma-aminobutyric acid receptor subunit alpha-1

Rattus norvegicus · SINGLE PROTEIN · 2 qualifying assays · 1 documents · best pChEMBL 4.64

Experimental evidence source: ChEMBL

5-hydroxytryptamine receptor 2B

Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 1 documents · best pChEMBL 4.55

Experimental evidence source: ChEMBL

5-hydroxytryptamine receptor 1A

Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 1 documents

Experimental evidence source: ChEMBL

Safety & Handling

Safety and handling reference content is available through documentation requests.

For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.

Preliminary Safety Reference

For supplier-issued SDS or COA, submit a documentation request.

Safety Reference / SDS Request

Names & Synonyms / External Identifiers

Chemical Name

Encorafenib

Names & Synonyms

BraftoviLGX 818Methyl N-[(2S)-1-({4-[3-(5-chloro-2-fluoro-3-methanesulfonamidophenyl)-1-(propan-2-yl)-1H-pyrazol-4-yl]pyrimidin-2-yl}amino)propan-2-yl]carbamateencorafenibummethyl N-((2S)-1-((4-(3-(5-chloro-2-fluoro-3-(methanesulfonamido)phenyl)-1-propan-2-ylpyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate
Show all synonyms
methyl N-((2S)-1-((4-(3-(5-chloro-2-fluoro-3-methanesulfonamidophenyl)-1-(propan-2-yl)-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamateCarbamic acid, N-[(1S)-2-[[4-[3-[5-chloro-2-fluoro-3-[(methylsulfonyl)amino]phenyl]-1-(1-methylethyl)-1H-pyrazol-4-yl]-2-pyrimidinyl]amino]-1-methylethyl]-, methyl esterEncorafenib (LGX818)(S)-Methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate(S)-Methyl [1-[[4-[3-[5-chloro-2-fluoro-3-(methylsulfonamido)phenyl]-1-isopropyl-1H-pyrazol-4-yl]pyrimidin-2-yl]amino]propan-2-yl]carbamatemethyl (S)-(1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamateEncorafenib [USAN:INN]Braftovi (TN)CARBAMIC ACID, N-((1S)-2-((4-(3-(5-CHLORO-2-FLUORO-3-((METHYLSULFONYL)AMINO)PHENYL)-1-(1-METHYLETHYL)-1H-PYRAZOL-4-YL)-2-PYRIMIDINYL)AMINO)-1-METHYLETHYL)-, METHYL ESTEREncorafenib (Standard)ENCORAFENIB [MI]LGX-818(Encorafenib)ENCORAFENIB [INN]ENCORAFENIB [JAN]
External Identifiers
EC NUMBER: 815-119-0DSSTOX SUBSTANCE ID: DTXSID00155347CHEMBL ID: CHEMBL3301612UNII: 8L7891MRB6DRUGBANK ID: DB11718HMDB ID: HMDB0304887KEGG ID: D11053METABOLOMICS WORKBENCH ID: 152829NCI THESAURUS CODE: C98283PHARMGKB ID: PA166179872RXCUI: 2049106WIKIDATA ID: Q15409405
Literature & Patent References
DOI 10.1021/acs.jmedchem.4c00998Identification of the Clinical Candidate <b>PF-07284890</b> (<b>ARRY-461</b>), a Highly Potent and Brain Penetrant BRAF Inhibitor for the Treatment of Cancer.PMID 39077892Identification of the Clinical Candidate <b>PF-07284890</b> (<b>ARRY-461</b>), a Highly Potent and Brain Penetrant BRAF Inhibitor for the Treatment of Cancer.DOI 10.1016/j.ejmech.2023.115928Unlocking the synthetic approaches and clinical application of approved small-molecule drugs for gastrointestinal cancer treatment: A comprehensive exploration.DOI 10.1038/s41467-023-40064-9A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs.DOI 10.6019/EOS300108ECBD screening data for assay EOS300108PMID 37468498A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs.PMID 37944387Unlocking the synthetic approaches and clinical application of approved small-molecule drugs for gastrointestinal cancer treatment: A comprehensive exploration.DOI 10.1016/j.ejmech.2021.113277Design, synthesis, biological evaluation, and docking studies of novel (imidazol-5-yl)pyrimidine-based derivatives as dual BRAF/p38α inhibitors.

Documentation & Compliance Facts

Compliance Facts

Shipment review: Required

Documentation available by request

Certificate of Analysis (COA): By request

Supplier Safety Data Sheet (SDS): By request

Purity and pack size confirmation: By request

Availability and lead time review: Confirmed by RFQ

Shipment documentation review: By request

For supplier-issued documentation by request, use the RFQ actions on this page.Review preliminary safety reference

What happens after RFQ

  1. 1We review the CAS identity, quantity, and documentation request.
  2. 2We check sourcing options, supplier availability, COA/SDS, purity, pack size, and lead time.
  3. 3We review destination and shipment documentation needs when applicable.
  4. 4We follow up with a quotation or clarification request.

Text Reference Cues

Show non-linked catalog cues

Non-public related references

Methyl (S)-(1-((4-(3-(3-amino-5-chloro-2-fluorophenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamateCAS 1269440-78-9
Methyl N-[(1S)-2-[[4-[3-iodo-1-(1-methylethyl)-1H-pyrazol-4-yl]-2-pyrimidinyl]amino]-1-methylethyl]carbamateCAS 1269440-60-9
2-Chloro-4-(3-iodo-1-(1-methylethyl)-1H-pyrazol-4-yl)pyrimidineCAS 1269440-58-5
Carbamic acid, N-(3-bromo-5-chloro-2-fluorophenyl)-, 1,1-dimethylethyl esterCAS 1269232-94-1
Carbamic acid, N-[(1S)-2-amino-1-methylethyl]-, methyl ester, hydrochloride (1:1)CAS 1229025-32-4

Non-public references are shown as text only and do not imply equivalence, availability, or shared use.

Catalog navigation

Related Catalog Entries

Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.

CAS 1269440-78-9Methyl (S)-(1-((4-(3-(3-amino-5-chloro-2-fluorophenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamateCAS 1269440-60-9Methyl N-[(1S)-2-[[4-[3-iodo-1-(1-methylethyl)-1H-pyrazol-4-yl]-2-pyrimidinyl]amino]-1-methylethyl]carbamateCAS 107724-20-9EplerenoneCAS 181695-72-7ValdecoxibCAS 22204-53-1NaproxenCAS 1187594-09-7BaricitinibCAS 319460-85-0AxitinibCAS 1002310-00-0Tert-butyl 1-(2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethylcarbamateCAS 1005174-17-3(E)-3-(2-Propyl-6-(trifluoromethyl)pyridin-3-yl)acrylic acidCAS 1018125-49-92-(3-Cyclopropyl-6-ethyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acid

RFQ questions for CAS 1269440-17-6

What are the key identifiers for Encorafenib (CAS 1269440-17-6)?

Encorafenib is identified by CAS 1269440-17-6, with molecular formula C22H27ClFN7O4S, molecular weight 540, InChIKey CMJCXYNUCSMDBY-ZDUSSCGKSA-N.

Does CAS 1269440-17-6 have reported biological target evidence?

ChEMBL contains qualifying experimental assay evidence associated with Serine/threonine-protein kinase B-raf, Mitogen-activated protein kinase 14, Gamma-aminobutyric acid receptor subunit alpha-1, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 1A. These records do not establish therapeutic efficacy or clinical use.

Can I request a COA for CAS 1269440-17-6?

Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.

Can I request supplier SDS for Encorafenib?

Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.

Is CAS 1269440-17-6 available for quotation?

Availability, pack size, lead time, and pricing are confirmed through RFQ.

Can MolGraph support bulk sourcing or custom synthesis review?

Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.